J. Weening and J. Jennette, Historical milestones in renal pathology, Virchows Archiv, vol.54, issue.25, pp.3-11, 2012.
DOI : 10.1007/s00428-012-1254-7

J. Berg and J. Weening, Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome, Clin Science, vol.107, pp.125-136, 2004.

D. Agati, V. Kaskel, F. Falk, and R. , Focal Segmental Glomerulosclerosis, New England Journal of Medicine, vol.365, issue.25, pp.2398-2411, 2011.
DOI : 10.1056/NEJMra1106556

G. Genovese, D. Friedman, M. Ross, L. Lecordier, P. Uzureau et al., Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans, Science, vol.329, issue.5993, pp.841-845, 2010.
DOI : 10.1126/science.1193032

C. Wei, E. Hindi, S. Li, J. Fornoni, A. Goes et al., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, Nature Medicine, vol.119, issue.8, pp.952-960, 2011.
DOI : 10.1159/000093259

R. Maas, J. Wetzels, and J. Deegens, Serum-soluble urokinase receptor concentration in primary FSGS, Kidney International, vol.81, issue.10, pp.1043-1044, 2012.
DOI : 10.1038/ki.2012.32

H. Debiec, F. Lefeu, M. Kemper, P. Niaudet, G. Deschênes et al., Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin, New England Journal of Medicine, vol.364, issue.22, pp.2101-2111, 2011.
DOI : 10.1056/NEJMoa1013792

L. Beck, . Jr, R. Bonegio, G. Lambeau, D. Beck et al., Receptor as Target Antigen in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009.
DOI : 10.1056/NEJMoa0810457
URL : https://hal.archives-ouvertes.fr/hal-00417718

J. Hofstra, H. Debiec, C. Short, T. Pellé, R. Kleta et al., Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy, Journal of the American Society of Nephrology, vol.23, issue.10, 2012.
DOI : 10.1681/ASN.2012030242
URL : https://hal.archives-ouvertes.fr/inserm-00919117

H. Debiec and P. Ronco, R Glomerular Deposits in Membranous Nephropathy, New England Journal of Medicine, vol.364, issue.7, pp.689-90, 2011.
DOI : 10.1056/NEJMc1011678

L. Beck, . Jr, F. Fervenza, D. Beck, R. Bonegio et al., Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy, Journal of the American Society of Nephrology, vol.22, issue.8, pp.1543-50, 2011.
DOI : 10.1681/ASN.2010111125

H. Debiec, L. Martin, C. Jouanneau, G. Dautin, L. Mesnard et al., Autoantibodies specific for the phospholipase A2 receptor in recurrentand De Novo membranous nephropathy, Am J Transplant, 2011.

P. Ruggenenti, P. Cravedi, A. Chianca, A. Perna, B. Ruggiero et al., Rituximab in Idiopathic Membranous Nephropathy, Journal of the American Society of Nephrology, vol.23, issue.8, pp.1416-1441, 2012.
DOI : 10.1681/ASN.2012020181

M. Murtas, C. Bruschi, M. Candiano, G. Moroni, G. Magistroni et al., Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.7, issue.9, pp.1394-400, 2012.
DOI : 10.2215/CJN.02170312

P. Lyons, T. Rayner, S. Trivedi, J. Holle, R. Watts et al., Genetically Distinct Subsets within ANCA-Associated Vasculitis, New England Journal of Medicine, vol.367, issue.3, pp.214-223, 2012.
DOI : 10.1056/NEJMoa1108735
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773907

F. Van-der-woude, N. Rasmussen, S. Lobatto, A. Wiik, H. Permin et al., AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS, The Lancet, vol.325, issue.8426, pp.425-434, 1985.
DOI : 10.1016/S0140-6736(85)91147-X

C. Kallenberg, Pathogenesis of ANCA-Associated Vasculitis, an Update, Clinical Reviews in Allergy & Immunology, vol.14, issue.S10, pp.224-231, 2011.
DOI : 10.1007/s12016-011-8258-y

M. Noris, F. Mescia, and G. Remuzzi, STEC-HUS, atypical HUS and TTP are all diseases of complement activation, Nature Reviews Nephrology, vol.46, issue.11, pp.622-633, 2012.
DOI : 10.1038/nrneph.2012.195

M. Chen, M. Daha, and C. Kallenberg, The complement system in systemic autoimmune disease, Journal of Autoimmunity, vol.34, issue.3, pp.276-286, 2010.
DOI : 10.1016/j.jaut.2009.11.014

S. Sethi and F. Fervenza, Membranoproliferative Glomerulonephritis ??? A New Look at an Old Entity, New England Journal of Medicine, vol.366, issue.12, pp.1119-1131, 2012.
DOI : 10.1056/NEJMra1108178

D. Agati, V. Bomback, and A. , C3 glomerulopathy: what's in a name?, Kidney International, vol.82, issue.4, pp.379-381, 2012.
DOI : 10.1038/ki.2012.80

J. Zuber, F. Fakhouri, L. Roumenina, C. Loirat, V. Frémeaux-bacchi et al., Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nature Reviews Nephrology, vol.26, issue.11, pp.643-657, 2012.
DOI : 10.1038/nrneph.2012.214

J. Weening, D. Agati, V. Schwartz, M. Seshan, S. Alpers et al., The classification of glomerulonephritis in systemic lupus erythematosus revisited, Kidney International, vol.65, issue.2, pp.521-530, 2004.
DOI : 10.1111/j.1523-1755.2004.00443.x

A. Berden, F. Ferrario, E. Hagen, D. Jayne, J. Jennette et al., Histopathologic Classification of ANCA-Associated Glomerulonephritis, Journal of the American Society of Nephrology, vol.21, issue.10, pp.1628-1636, 2010.
DOI : 10.1681/ASN.2010050477

D. Cattran, R. Coppo, H. Cook, J. Feehally, I. Roberts et al., The Oxford classification of IgA nephropathy: pathology definitions, correlations and classification, Kidney Int, vol.76, pp.546-556, 2009.

N. Hiramatsu, T. Kuroiwa, H. Ikeuchi, A. Maeshima, Y. Kaneko et al., Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions, Rheumatology, vol.47, issue.5, pp.702-707, 2008.
DOI : 10.1093/rheumatology/ken019